Bo Kruse, EVP, CFO, Secretary & Treasurer at Y-mAbs Therapeutics, Inc. (YMAB), sold 4,000 shares at $7.97 ($32K) on 2022-02-04, disclosed to the SEC on 2022-02-07.
Scheduled sale ($32k) by EVP, CFO, Secretary & Treasurer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| YMAB | SELL | 2022-01-25 | $39K | — | Filing → |
| YMAB | SELL | 2022-01-05 | $68K | — | Filing → |
| YMAB | SELL | 2021-12-23 | $65K | — | Filing → |